X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (137) 137
humans (119) 119
life sciences (88) 88
male (81) 81
female (77) 77
middle aged (69) 69
aged (62) 62
immunology (57) 57
adult (42) 42
hematology (34) 34
amyloidosis (31) 31
prognosis (30) 30
analysis (29) 29
oncology (29) 29
bortezomib (28) 28
abridged index medicus (26) 26
retrospective studies (25) 25
aged, 80 and over (24) 24
dexamethasone (23) 23
diagnosis (23) 23
survival (23) 23
chemotherapy (22) 22
al amyloidosis (21) 21
stem-cell transplantation (19) 19
melphalan (18) 18
treatment outcome (18) 18
cancer (17) 17
multiple myeloma (16) 16
prospective studies (16) 16
animals (15) 15
biochemistry & molecular biology (15) 15
medicine, general & internal (15) 15
multiple-myeloma (15) 15
antineoplastic combined chemotherapy protocols - therapeutic use (14) 14
dexamethasone - administration & dosage (14) 14
france (14) 14
transplantation (14) 14
amyloidosis - diagnosis (13) 13
light-chain amyloidosis (13) 13
research (13) 13
disease (12) 12
disease-free survival (12) 12
microbiology (12) 12
survival rate (12) 12
adolescent (11) 11
amyloidosis - drug therapy (11) 11
amyloidosis - therapy (11) 11
care and treatment (11) 11
cyclophosphamide (11) 11
dexamethasone - therapeutic use (11) 11
kaplan-meier estimate (11) 11
primary systemic amyloidosis (11) 11
survival analysis (11) 11
amyloidosis - mortality (10) 10
cardiac & cardiovascular systems (10) 10
drug therapy, combination (10) 10
expression (10) 10
immunoglobulin light chains (10) 10
immunoglobulins (10) 10
phylogeny (10) 10
sciences of the universe (10) 10
therapy (10) 10
follow-up studies (9) 9
health aspects (9) 9
immunoglobulin light chains - blood (9) 9
leukemia (9) 9
patients (9) 9
thalidomide - analogs & derivatives (9) 9
urology & nephrology (9) 9
combined modality therapy (8) 8
earth sciences (8) 8
genes (8) 8
genomics (8) 8
hematopoietic stem cell transplantation (8) 8
immunohistochemistry (8) 8
medicine, research & experimental (8) 8
melphalan - administration & dosage (8) 8
melphalan - therapeutic use (8) 8
recurrence (8) 8
amyloidosis - blood (7) 7
biopsy (7) 7
cohort studies (7) 7
computer science (7) 7
disease progression (7) 7
genetics (7) 7
genomes (7) 7
infections (7) 7
lenalidomide (7) 7
monoclonal gammopathy (7) 7
multiple myeloma - drug therapy (7) 7
proteins (7) 7
remission induction (7) 7
studies (7) 7
young adult (7) 7
amyloidosis - pathology (6) 6
antineoplastic combined chemotherapy protocols (6) 6
bacteria (6) 6
biodiversity (6) 6
brain natriuretic peptide (6) 6
case-control studies (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


ONCOLOGY (United States), ISSN 0890-9091, 12/2013, Volume 27, Issue 12, pp. 1260 - 1262
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2016, Volume 15, Issue 11, pp. 1104 - 1105
  The second step was understanding why more than 95% of the time the plasma cells are λ light chain restricted in POEMS syndrome; in this disorder, the... 
Neurology | CLINICAL NEUROLOGY | Thalidomide | Drugs | Plasma | Immunoglobulins | Multiple myeloma | Index Medicus
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 2, pp. 196 - 206
Summary Background Post-transplantation lymphoproliferative disorder (PTLD) develops in 1–10% of transplant recipients and can be Epstein–Barr virus (EBV)... 
Hematology, Oncology and Palliative Medicine | SOLID-ORGAN TRANSPLANTATION | DISTINCT ENTITY | VIRAL LOAD | ONCOLOGY | IMMUNOSUPPRESSION | DISEASE | LYMPHOMA | SINGLE-CENTER | II TRIAL | RECIPIENTS | EPSTEIN-BARR-VIRUS | Doxorubicin - therapeutic use | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prednisolone - administration & dosage | Prospective Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Organ Transplantation - pathology | Cyclophosphamide - therapeutic use | Epstein-Barr Virus Infections - therapy | Vincristine - administration & dosage | Adult | Female | Herpesvirus 4, Human - pathogenicity | Prednisolone - therapeutic use | France | Lymphoproliferative Disorders - etiology | Doxorubicin - administration & dosage | Antigens, CD20 - immunology | Rituximab | Lymphoproliferative Disorders - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Organ Transplantation - adverse effects | Adolescent | Vincristine - therapeutic use | Epstein-Barr Virus Infections - diagnosis | Lymphoproliferative Disorders - drug therapy | Aged | Germany | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Anthracyclines | Cyclophosphamide | Chemotherapy | Corticosteroids | Organ transplant recipients | Clinical trials | Product development | Epstein-Barr virus | Universities and colleges | Prednisolone | Cancer | Index Medicus | Antibodies, Monoclonal, Murine-Derived | Antigens, CD20 | Lymphoproliferative Disorders | Antineoplastic Combined Chemotherapy Protocols | Organ Transplantation | Vincristine | Doxorubicin | Herpesvirus 4, Human | Life Sciences | Immunology | Epstein-Barr Virus Infections
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 389 - 400
Journal Article
Blood, ISSN 0006-4971, 04/2017, Volume 129, Issue 17, pp. 2342 - 2343
In this issue of Blood, Kwong et al provide strong evidence that immune checkpoints inhibitors are remarkably efficient in treatment of relapsing natural... 
HEMATOLOGY | Index Medicus | Abridged Index Medicus | Life Sciences | Cancer
Journal Article
Néphrologie & Thérapeutique, ISSN 1769-7255, 04/2019, Volume 15, pp. S115 - S121
Journal Article
Nephrologie et Thérapeutique, ISSN 1769-7255, 04/2019, Volume 15, pp. S115 - S121
The publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the reason for the removal of the... 
Journal Article
Nephrologie et Therapeutique, ISSN 1769-7255, 2019
AL amyloidosis is caused by the conversion of monoclonal immunoglobulin light chains into amyloid fibrillar aggregates that deposit in tissue and lead to organ... 
AL amyloidosis | Cyclophosphamide | Bortezomib | Dexamethasone | Treatment | Haematologic response | Melphalan | Free light chains
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2007, Volume 357, Issue 11, pp. 1083 - 1093
Journal Article
Blood, ISSN 0006-4971, 05/2016, Volume 127, Issue 21, pp. 2569 - 2574
Journal Article
Kidney International, ISSN 0085-2538, 11/2015, Volume 88, Issue 5, pp. 1135 - 1143
Monoclonal immunoglobulin deposition disease (MIDD) is a rare complication of plasma cell disorders, defined by linear Congo red-negative deposits of... 
monoclonalimmunoglobulin | free light chains | bortezomib | monoclonalgammopathy of renal significance | monodonalimmunoglobulir deposition disease | Monoclonal gammopathy of renal significance | Free light chains | Bortezomib | Monoclonal immunoglobulin deposition disease | Monoclonal immunoglobulin | MULTIPLE-MYELOMA | DEXAMETHASONE | CYCLOPHOSPHAMIDE | monoclonal gammopathy of renal significance | CHEMOTHERAPY | IMPAIRMENT | monoclonal immunoglobulin deposition disease | GAMMOPATHY | monoclonal immunoglobulin | LIGHT-CHAIN AMYLOIDOSIS | UROLOGY & NEPHROLOGY | REVERSIBILITY | STEM-CELL TRANSPLANTATION | AL AMYLOIDOSIS | Kidney Diseases - physiopathology | Cyclophosphamide - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Male | Thalidomide - analogs & derivatives | Glomerular Filtration Rate - drug effects | Multiple Myeloma - drug therapy | Waldenstrom Macroglobulinemia - drug therapy | Waldenstrom Macroglobulinemia - complications | Female | Retrospective Studies | Multiple Myeloma - blood | Waldenstrom Macroglobulinemia - blood | Glomerular Basement Membrane - metabolism | Dexamethasone - administration & dosage | Kidney Diseases - pathology | Multiple Myeloma - complications | Survival Rate | Thalidomide - administration & dosage | Disease Progression | Immunoglobulin Light Chains - metabolism | Kidney Diseases - immunology | Proteinuria - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Bortezomib - therapeutic use | Immunoglobulin Heavy Chains - metabolism | Aged | Index Medicus
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 5/2008, Volume 46, Issue 10, pp. 1547 - 1554
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2013, Volume 31, Issue 1, pp. 104 - 110
Journal Article
Nephrologie & therapeutique, 04/2019, Volume 15 Suppl 1, p. S115
The publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the reason for the removal of the... 
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2017, Volume 76, pp. 183 - 187
Abstract Chemotherapy combining cyclophosphamide, bortezomib and dexamethasone is widely used in light-chain amyloidosis. The benefit is limited in patients... 
Hematology, Oncology and Palliative Medicine | Heart failure | NT-proBNP | Dexamethasone | Treatment | Mortality mortality | Cardiac amyloidosis | Free light-chains | Light-chain (AL) amyloidosis | MULTIPLE-MYELOMA | SURVIVAL | DIAGNOSIS | PROGNOSIS | INVOLVEMENT | CARDIOTOXICITY | TOXICITY | ONCOLOGY | DYSFUNCTION | AL AMYLOIDOSIS | MELPHALAN | Cyclophosphamide - administration & dosage | Arrhythmias, Cardiac - chemically induced | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Dexamethasone - adverse effects | Male | Death, Sudden, Cardiac - etiology | Troponin T - blood | Peptide Fragments - blood | Aged, 80 and over | Female | Heart Diseases - blood | Retrospective Studies | Natriuretic Peptide, Brain - blood | Immunoglobulin Light-chain Amyloidosis | Immunoglobulin kappa-Chains - blood | Immunoglobulin lambda-Chains - blood | Dexamethasone - administration & dosage | Water-Electrolyte Imbalance - chemically induced | Amyloidosis - drug therapy | Amyloidosis - blood | Bortezomib - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Heart Diseases - drug therapy | Immunoglobulin Light Chains - blood | Cyclophosphamide | Chemotherapy | Bortezomib | Analysis | Cardiac patients | Amyloidosis | Cardiology | Natriuretic peptides | Steroids | Cancer | Mortality | Corticoids | Heart | Brain natriuretic peptide | Brain | Peptides | Medical treatment | Cardiovascular disease | Chains | Patients | Troponin | Calcium-binding protein | Light chains | Heart diseases | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2008, Volume 26, Issue 15, pp. 2512 - 2518
Journal Article
Blood, ISSN 0006-4971, 02/2011, Volume 117, Issue 6, pp. 1834 - 1839
Journal Article